Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9031)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 28, 2021 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fincham REA, Delvecchio FR, Goulart MR, Yeong JPS, Kocher HM. Natural killer cells in pancreatic cancer stroma. World J Gastroenterol 2021; 27(24): 3483-3501 [PMID: 34239264 DOI: 10.3748/wjg.v27.i24.3483] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i24/3483.htm |
| Number | Citing Articles |
| 1 |
Yu-Hsuan Hung, Li-Tzong Chen, Wen-Chun Hung. The Trinity: Interplay among Cancer Cells, Fibroblasts, and Immune Cells in Pancreatic Cancer and Implication of CD8+ T Cell-Orientated Therapy. Biomedicines 2022; 10(4): 926 doi: 10.3390/biomedicines10040926
|
| 2 |
Duancheng Guo, Longyun Ye, Weiding Wu, Xianjun Yu, Kaizhou Jin. Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer. Acta Biochimica et Biophysica Sinica 2023; 55(6): 923 doi: 10.3724/abbs.2023045
|
| 3 |
Nicky A. Beelen, Merel R. Aberle, Virginia Bruno, Steven W. M. Olde Damink, Gerard M. J. Bos, Sander S. Rensen, Lotte Wieten. Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer organoids. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1133796
|
| 4 |
Martina S. Lutz, Kevin Wang, Gundram Jung, Helmut R. Salih, Ilona Hagelstein. An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1343929
|
| 5 |
Catarina Nascimento, Andreia Gameiro, Jorge Correia, João Ferreira, Fernando Ferreira. The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications. Cells 2022; 11(16): 2578 doi: 10.3390/cells11162578
|
| 6 |
Praveen Bhoopathi, Padmanabhan Mannangatti, Swadesh K. Das, Paul B. Fisher, Luni Emdad. Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159: 285 doi: 10.1016/bs.acr.2023.02.010
|
| 7 |
Wei Liu, Dongwei Hu, Jinjie Li, Qigang Xu, Zongjing Chen, Bo Xu. CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2L. Cancer Biology & Therapy 2023; 24(1) doi: 10.1080/15384047.2023.2216041
|
| 8 |
Hyun-Ah Kim, Hyunsoo Kim, Min-Kyung Nam, Jong Kook Park, Moo-Yeal Lee, Seok Chung, Kyung-Mi Lee, Hyo-Jeong Kuh. Suppression of the antitumoral activity of natural killer cells under indirect coculture with cancer-associated fibroblasts in a pancreatic TIME-on-chip model. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03064-9
|
| 9 |
Peipei Wang, Congliang Chen, Kexin Lin, Yu Zhang, Junmei Hu, Tongbo Zhu, Xia Wang. The BCL2-associated athanogene-3–Interferon-induced transmembrane protein 2 axis enhances pancreatic ductal adenocarcinoma growth via the Mitogen-activated protein kinase signaling pathway. Carcinogenesis 2024; doi: 10.1093/carcin/bgae053
|
| 10 |
Sofian Benkhaled, Cedric Peters, Nicolas Jullian, Tatjana Arsenijevic, Julie Navez, Dirk Van Gestel, Luigi Moretti, Jean-Luc Van Laethem, Christelle Bouchart. Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?. Cancers 2023; 15(3): 768 doi: 10.3390/cancers15030768
|
| 11 |
Virender Kumar, Ram I. Mahato. Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticles. Cancer Letters 2023; 579: 216462 doi: 10.1016/j.canlet.2023.216462
|
| 12 |
Qi Lu, Tian Liu, Zeyu Han, Jian Zhao, Xiaoyuan Fan, Helin Wang, Jiaxuan Song, Hao Ye, Jin Sun. Revolutionizing cancer treatment: The power of cell-based drug delivery systems. Journal of Controlled Release 2023; 361: 604 doi: 10.1016/j.jconrel.2023.08.023
|
| 13 |
Patrick V. Lawrence, Krisha Desai, Christopher Wadsworth, Nagina Mangal, Hemant M. Kocher, Nagy Habib, Anguraj Sadanandam, Mikael H. Sodergren. A Case Report on Longitudinal Collection of Tumour Biopsies for Gene Expression-Based Tumour Microenvironment Analysis from Pancreatic Cancer Patients Treated with Endoscopic Ultrasound Guided Radiofrequency Ablation. Current Oncology 2022; 29(10): 6754 doi: 10.3390/curroncol29100531
|
| 14 |
Zhenglin Ou, Yebin Lu, Dayong Xu, Zhen Luo. Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275/AXIN2 in natural killer cells. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1271603
|